| Literature DB >> 31423757 |
Sophie E Carter1,2, Richard Draijer3, Sophie M Holder1, Louise Brown4, Dick H J Thijssen1,5, Nicola D Hopkins1.
Abstract
Breaking up prolonged sitting with physical activity (PA) breaks prevents conduit artery dysfunction. However, the optimal break strategy to achieve this, in terms of the frequency or duration of PA, is not known. This study assessed the effect of breaking up sitting with different PA break strategies on lower limb peripheral artery endothelial function. Fifteen participants (10 male, 35.8 ± 10.2 years, BMI: 25.5 ± 3.2 kg m-2 ) completed, on separate days, three 4-h conditions in a randomized order: (1) uninterrupted sitting (SIT), (2) sitting with 2-min light-intensity walking breaks every 30 min (2WALK), or (3) sitting with 8-min light-intensity walking breaks every 2 h (8WALK). At baseline and 4 h, superficial femoral artery function (flow-mediated dilation; FMD), blood flow, and shear rate (SR) were assessed using Doppler ultrasound. For each condition, the change in outcome variables was calculated and data were statistically analyzed using a linear mixed model. There was no significant main effect for the change in FMD (P = 0.564). A significant main effect was observed for the change in blood flow (P = 0.022), with post hoc analysis revealing a greater reduction during SIT (-42.7 ± 14.2 mL·min) compared to 8WALK (0.45 ± 17.7 mL·min; P = 0.012). There were no significant main effects for mean, antegrade, or retrograde SR (P > 0.05). Superficial femoral artery blood flow, but not FMD, was reduced following uninterrupted sitting. This decline in blood flow was prevented with longer duration, less frequent walking breaks rather than shorter, more frequent breaks suggesting the dose (duration and frequency) of PA may influence the prevention of sitting-induced decreases in blood flow.Entities:
Keywords: Blood flow; flow-mediated dilation; physical activity breaks; sedentary behavior; shear rate
Mesh:
Year: 2019 PMID: 31423757 PMCID: PMC6698486 DOI: 10.14814/phy2.14190
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Figure 1Experimental design for the three test conditions, completed in a randomized order, on three separate days. (A) 4‐h uninterrupted sitting (SIT), (B) Sitting with 2‐min treadmill walking breaks every 30 min (2WALK), (C) Sitting with 8‐min treadmill walking breaks every 120 min (8WALK). FMD, flow‐mediated dilation; SR, shear rate; HR, heart rate; MAP, mean arterial pressure
For each condition, heart rate (HR), mean arterial pressure (MAP), superficial femoral artery flow‐mediated dilation (FMD), blood flow, and shear rate (SR) at baseline, 4 h, and the overall change (∆) with statistically adjusted baseline covariate control (n = 15). (Values are mean ± SD [95% confidence interval])
| SIT | 2WALK | 8WALK |
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 4 h | ∆ | Baseline | 4 h | ∆ | Baseline | 4 h | ∆ | ||
| HR (bpm) | 59 ± 12 | 56 ± 8 | −2 ± 6 [−5, 1] | 58 ± 9 | 55 ± 12 | −3 ± 10 [−9, 3] | 56 ± 8 | 55 ± 7 | −2 ± 7 [−6, 2] | 0.895 |
| MAP (mmHg) | 83 ± 10 | 84 ± 9 | 2 ± 7 [−2, 6] | 80 ± 7 | 84 ± 8 | 3 ± 6 [−1, 7] | 81 ± 8 | 83 ± 10 | 2 ± 8 [−3, 7] | 0.778 |
| FMD (%) | 5.5 ± 3.1 | 6.9 ± 4.0 | 0.9 ± 3.7 [−1.3, 3.1] | 6.7 ± 3.4 | 7.4 ± 3.1 | 1.0 ± 3.2 [−0.9, 2.8] | 6.7 ± 3.8 | 8.9 ± 4.6 | 2.4 ± 4.6 [−0.3, 5.2] | 0.564 |
| FMD (%) allometric modelling | 5.8 ± 2.6 | 6.9 ± 3.3 | 0.7 ± 3.9 [−1.7, 3.0] | 6.9 ± 2.6 | 7.4 ± 2.8 | 1.0 ± 3.1 [−0.8, 2.9] | 6.7 ± 3.2 | 8.0 ± 3.4 | 2.5 ± 4.2 [−0.1, 5.1] | 0.491 |
| SR AUC (s−1 × 103) | 16.9 ± 11.4 | 16.9 ± 10.4 | −0.7 ± 9.9 [−6.7, 5.3] | 15.6 ± 10.1 | 18.5 ± 10.2 | 1.1 ± 10.8 [−5.4, 7.7] | 20.9 ± 10.2 | 29.3 ± 20.7 | 10.9 ± 19.5 [−1.0, 22.8] | 0.076 |
| Baseline diameter (cm) | 0.62 ± 0.11 | 0.61 ± 0.11 | −0.02 ± 0.04 [−0.03, −0.00] | 0.62 ± 0.10 | 0.62 ± 0.11 | −0.00 ± 0.04 [−0.02, 0.02] | 0.63 ± 0.08 | 0.61 ± 0.12 | −0.02 ± 0.07 [−0.06, 0.01] | 0.255 |
| Mean blood flow (mL·min) | 182.4 ± 66.7 | 151.8 ± 56.4 | −42.7 ± 53.1 | 213.8 ± 109.7 | 178.1 ± 91.0 | −19.8 ± 91.7 [−72.7, 33.2] | 191.6 ± 81.5 | 195.9 ± 65.5 | 0.45 ± 66.2 [−37.9, 38.8] | 0.022 |
| Vascular conductance (mL·min·mmHg) | 2.2 ± 0.8 | 1.8 ± 0.7 | −0.6 ± 0.7 | 2.6 ± 1.2 | 2.2 ± 1.1 | −0.3 ± 1.1 [−0.9, 0.4] | 2.3 ± 1.0 | 2.3 ± 0.8 | −0.1 ± 0.9 [−0.6, 0.4] | 0.046 |
| Mean SR (s−1) | 61.6 ± 25.3 | 57.5 ± 28.3 | −4.4 ± 16.5 [−14.0, 5.2] | 65.3 ± 21.5 | 66.8 ± 55.2 | 1.9 ± 48.6 [−26.2, 30.0] | 63.9 ± 34.8 | 78.2 ± 61.8 | 14.4 ± 64.0 [−22.6, 51.4] | 0.390 |
| AntegradeSR (s−1) | 82.1 ± 27.4 | 76.2 ± 27.6 | −5.8 ± 16.5 [−15.3, 3.8] | 83.4 ± 24.6 | 82.0 ± 52.9 | −0.9 ± 44.5 [−26.6, 24.8] | 79.9 ± 35.9 | 91.6 ± 59.6 | 11.2 ± 60.2 [−23.6, 45.9] | 0.402 |
| RetrogradeSR (s−1) | −20.5 ± 11.2 | −18.7 ± 8.3 | 0.9 ± 4.5 [−1.7, 3.5] | −18.1 ± 7.9 | −15.2 ± 11.1 | 3.0 ± 8.6 [−2.1, 8.0] | −16.0 ± 7.3 | −13.4 ± 9.3 | 3.5 ± 7.9 [−1.1, 8.0] | 0.464 |
SIT, uninterrupted sitting; 2WALK, 2‐min walking breaks; 8WALK, 8‐min walking breaks; HR, heart rate; MAP, mean arterial pressure; FMD, flow‐mediated dilation; SR, shear rate, AUC, area under the curve.
Delta change values expressed with statistically adjusted baseline covariate control.
Significantly different to 8WALK (P < 0.05).
Figure 2Change in superficial femoral artery (A) flow‐mediated dilation (FMD), (B) mean blood flow, and (C) vascular conductance measured at baseline and after 4 h of each experimental condition, with statistically adjusted baseline covariate control. SIT‐ uninterrupted sitting; 2WALK‐ 2‐min walking breaks; 8WALK‐ 8‐min walking breaks. Error bars = ±SD. *Significant difference between conditions (P < 0.05)
Figure 3Change in superficial femoral artery (A) mean, (B) antegrade, and (C) retrograde shear rate (SR) measured at baseline and after 4 h of each experimental condition, with statistically adjusted baseline covariate control. SIT‐ uninterrupted sitting; 2WALK‐ 2‐min walking breaks; 8WALK‐ 8‐min walking breaks. Error bars = ±SD
Heart rate (HR) and mean arterial pressure (MAP) every 30 min for each 4‐h condition (n = 15). (Values are mean ± SD)
| Time | ||||||||
|---|---|---|---|---|---|---|---|---|
| 30 min | 1 h | 1 h 30 min | 2 h | 2 h 30 min | 3 h | 3 h 30 min | 4 h | |
| HR (bpm) | ||||||||
| SIT | 64 ± 11 | 62 ± 9 | 61 ± 10 | 58 ± 10 | 60 ± 9 | 61 ± 10 | 61 ± 11 | 58 ± 10 |
| 2WALK | 62 ± 10 | 64 ± 12 | 61 ± 9 | 61 ± 10 | 58 ± 9 | 59 ± 10 | 59 ± 10 | 58 ± 12 |
| 8WALK | 65 ± 11 | 62 ± 12 | 61 ± 10 | 58 ± 10 | 57 ± 9 | 58 ± 10 | 59 ± 10 | 59 ± 13 |
| MAP (mmHg) | ||||||||
| SIT | 87 ± 8 | 86 ± 9 | 86 ± 9 | 85 ± 8 | 89 ± 10 | 85 ± 7 | 86 ± 9 | 85 ± 7 |
| 2WALK | 87 ± 14 | 87 ± 14 | 86 ± 12 | 88 ± 9 | 86 ± 12 | 86 ± 12 | 87 ± 10 | 88 ± 9 |
| 8WALK | 88 ± 12 | 86 ± 10 | 86 ± 10 | 86 ± 11 | 87 ± 8 | 87 ± 9 | 88 ± 12 | 88 ± 10 |
SIT, uninterrupted sitting; 2WALK, 2‐min walking breaks; 8WALK, 8‐min walking breaks; HR, heart rate; MAP, mean arterial pressure.
Significant main effect for time (P < 0.001). Indicates significantly reduced compared to 30 min (P < 0.001).